According to Sarepta Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 93,991,000. At the end of 2024 the company had 93,991,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2024 | 93.99 M | 5.74% |
2023 | 88.88 M | 1.44% |
2022 | 87.62 M | 9.7% |
2021 | 79.88 M | 1.76% |
2020 | 78.5 M | 5.83% |
2019 | 74.17 M | 8.05% |
2018 | 68.65 M | 6.81% |
2017 | 64.27 M | 17.68% |
2016 | 54.61 M | 21.69% |
2015 | 44.88 M | 8.66% |
2014 | 41.3 M | 9.86% |
2013 | 37.59 M | 64.72% |
2012 | 22.82 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | 1,248,000,000 | 1,227.79% | ๐บ๐ธ USA |
PTC Therapeutics
PTCT | 76,496,127 | -18.61% | ๐บ๐ธ USA |
Novavax NVAX | 103,429,000 | 10.04% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | 126,138,000 | 34.20% | ๐บ๐ธ USA |
Insmed INSM | 142,899,000 | 52.03% | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | 189,644,000 | 101.77% | ๐บ๐ธ USA |
Avidity Biosciences RNA | 74,097,000 | -21.17% | ๐บ๐ธ USA |